TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...

Carnegie Mellon researchers have used FRESH 3D bioprinting to create the first collagen-based microphysiologic systems, ...

"In people with Type 1 diabetes, the immune system starts to recognize pancreatic cells as something it needs to attack, and ...

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

A record entirely from the South, in a sector that has always been a thorn in the side. At the University Hospital of Palermo ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity (the ...